Global Solid Tumor Drug Market Research Report 2023

Solid Tumor Drug Market

According to new survey, global Solid Tumor Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Solid Tumor Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Solid Tumor Drug Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Small Molecules

1.2.3 Biologics

1.3 Market by Application

1.3.1 Global Solid Tumor Drug Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Oncology

1.3.3 Neurology

1.3.4 Radiology

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Solid Tumor Drug Market Perspective (2018-2029)

2.2 Solid Tumor Drug Growth Trends by Region

2.2.1 Global Solid Tumor Drug Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Solid Tumor Drug Historic Market Size by Region (2018-2023)

2.2.3 Solid Tumor Drug Forecasted Market Size by Region (2024-2029)

2.3 Solid Tumor Drug Market Dynamics

2.3.1 Solid Tumor Drug Industry Trends

2.3.2 Solid Tumor Drug Market Drivers

2.3.3 Solid Tumor Drug Market Challenges

2.3.4 Solid Tumor Drug Market Restraints

3.1 Global Top Solid Tumor Drug Players by Revenue

3.1.1 Global Top Solid Tumor Drug Players by Revenue (2018-2023)

3.1.2 Global Solid Tumor Drug Revenue Market Share by Players (2018-2023)

3.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Solid Tumor Drug Revenue

3.4 Global Solid Tumor Drug Market Concentration Ratio

3.4.1 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2022

3.5 Solid Tumor Drug Key Players Head office and Area Served

3.6 Key Players Solid Tumor Drug Product Solution and Service

3.7 Date of Enter into Solid Tumor Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Solid Tumor Drug Historic Market Size by Type (2018-2023)

4.2 Global Solid Tumor Drug Forecasted Market Size by Type (2024-2029)

5.1 Global Solid Tumor Drug Historic Market Size by Application (2018-2023)

5.2 Global Solid Tumor Drug Forecasted Market Size by Application (2024-2029)

6.1 North America Solid Tumor Drug Market Size (2018-2029)

6.2 North America Solid Tumor Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Solid Tumor Drug Market Size by Country (2018-2023)

6.4 North America Solid Tumor Drug Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Solid Tumor Drug Market Size (2018-2029)

7.2 Europe Solid Tumor Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Solid Tumor Drug Market Size by Country (2018-2023)

7.4 Europe Solid Tumor Drug Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Solid Tumor Drug Market Size (2018-2029)

8.2 Asia-Pacific Solid Tumor Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Solid Tumor Drug Market Size by Region (2018-2023)

8.4 Asia-Pacific Solid Tumor Drug Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Solid Tumor Drug Market Size (2018-2029)

9.2 Latin America Solid Tumor Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Solid Tumor Drug Market Size by Country (2018-2023)

9.4 Latin America Solid Tumor Drug Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Solid Tumor Drug Market Size (2018-2029)

10.2 Middle East & Africa Solid Tumor Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Solid Tumor Drug Market Size by Country (2018-2023)

10.4 Middle East & Africa Solid Tumor Drug Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Solid Tumor Drug Introduction

11.1.4 AstraZeneca Revenue in Solid Tumor Drug Business (2018-2023)

11.1.5 AstraZeneca Recent Development

11.2 Biogen

11.2.1 Biogen Company Detail

11.2.2 Biogen Business Overview

11.2.3 Biogen Solid Tumor Drug Introduction

11.2.4 Biogen Revenue in Solid Tumor Drug Business (2018-2023)

11.2.5 Biogen Recent Development

11.3 Baxter

11.3.1 Baxter Company Detail

11.3.2 Baxter Business Overview

11.3.3 Baxter Solid Tumor Drug Introduction

11.3.4 Baxter Revenue in Solid Tumor Drug Business (2018-2023)

11.3.5 Baxter Recent Development

11.4 Celgene Corporation

11.4.1 Celgene Corporation Company Detail

11.4.2 Celgene Corporation Business Overview

11.4.3 Celgene Corporation Solid Tumor Drug Introduction

11.4.4 Celgene Corporation Revenue in Solid Tumor Drug Business (2018-2023)

11.4.5 Celgene Corporation Recent Development

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Detail

11.5.2 Abbott Laboratories Business Overview

11.5.3 Abbott Laboratories Solid Tumor Drug Introduction

11.5.4 Abbott Laboratories Revenue in Solid Tumor Drug Business (2018-2023)

11.5.5 Abbott Laboratories Recent Development

11.6 Pfizer Inc

11.6.1 Pfizer Inc Company Detail

11.6.2 Pfizer Inc Business Overview

11.6.3 Pfizer Inc Solid Tumor Drug Introduction

11.6.4 Pfizer Inc Revenue in Solid Tumor Drug Business (2018-2023)

11.6.5 Pfizer Inc Recent Development

11.7 Amgen Limited & Amgen Ireland Limited

11.7.1 Amgen Limited & Amgen Ireland Limited Company Detail

11.7.2 Amgen Limited & Amgen Ireland Limited Business Overview

11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Introduction

11.7.4 Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2018-2023)

11.7.5 Amgen Limited & Amgen Ireland Limited Recent Development

11.8 Bristol-Myers Squibb Company

11.8.1 Bristol-Myers Squibb Company Company Detail

11.8.2 Bristol-Myers Squibb Company Business Overview

11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Introduction

11.8.4 Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2018-2023)

11.8.5 Bristol-Myers Squibb Company Recent Development

11.9 GlaxoSmithKline plc.

11.9.1 GlaxoSmithKline plc. Company Detail

11.9.2 GlaxoSmithKline plc. Business Overview

11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Introduction

11.9.4 GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2018-2023)

11.9.5 GlaxoSmithKline plc. Recent Development

11.10 F. Hoffmann-La Roche Ltd.

11.10.1 F. Hoffmann-La Roche Ltd. Company Detail

11.10.2 F. Hoffmann-La Roche Ltd. Business Overview

11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Introduction

11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2018-2023)

11.10.5 F. Hoffmann-La Roche Ltd. Recent Development

11.11 Eli Lilly and Company

11.11.1 Eli Lilly and Company Company Detail

11.11.2 Eli Lilly and Company Business Overview

11.11.3 Eli Lilly and Company Solid Tumor Drug Introduction

11.11.4 Eli Lilly and Company Revenue in Solid Tumor Drug Business (2018-2023)

11.11.5 Eli Lilly and Company Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Detail

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Solid Tumor Drug Introduction

11.12.4 Johnson & Johnson Revenue in Solid Tumor Drug Business (2018-2023)

11.12.5 Johnson & Johnson Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Small Molecules

    Table 3. Key Players of Biologics

    Table 4. Global Solid Tumor Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Solid Tumor Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Solid Tumor Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Solid Tumor Drug Market Share by Region (2018-2023)

    Table 8. Global Solid Tumor Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Solid Tumor Drug Market Share by Region (2024-2029)

    Table 10. Solid Tumor Drug Market Trends

    Table 11. Solid Tumor Drug Market Drivers

    Table 12. Solid Tumor Drug Market Challenges

    Table 13. Solid Tumor Drug Market Restraints

    Table 14. Global Solid Tumor Drug Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Solid Tumor Drug Market Share by Players (2018-2023)

    Table 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)

    Table 17. Ranking of Global Top Solid Tumor Drug Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Solid Tumor Drug Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Solid Tumor Drug Product Solution and Service

    Table 21. Date of Enter into Solid Tumor Drug Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Solid Tumor Drug Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Solid Tumor Drug Revenue Market Share by Type (2018-2023)

    Table 25. Global Solid Tumor Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Solid Tumor Drug Revenue Market Share by Type (2024-2029)

    Table 27. Global Solid Tumor Drug Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Solid Tumor Drug Revenue Market Share by Application (2018-2023)

    Table 29. Global Solid Tumor Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Solid Tumor Drug Revenue Market Share by Application (2024-2029)

    Table 31. North America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Solid Tumor Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Solid Tumor Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Solid Tumor Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Solid Tumor Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Solid Tumor Drug Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Solid Tumor Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Solid Tumor Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 46. AstraZeneca Company Detail

    Table 47. AstraZeneca Business Overview

    Table 48. AstraZeneca Solid Tumor Drug Product

    Table 49. AstraZeneca Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 50. AstraZeneca Recent Development

    Table 51. Biogen Company Detail

    Table 52. Biogen Business Overview

    Table 53. Biogen Solid Tumor Drug Product

    Table 54. Biogen Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 55. Biogen Recent Development

    Table 56. Baxter Company Detail

    Table 57. Baxter Business Overview

    Table 58. Baxter Solid Tumor Drug Product

    Table 59. Baxter Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 60. Baxter Recent Development

    Table 61. Celgene Corporation Company Detail

    Table 62. Celgene Corporation Business Overview

    Table 63. Celgene Corporation Solid Tumor Drug Product

    Table 64. Celgene Corporation Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 65. Celgene Corporation Recent Development

    Table 66. Abbott Laboratories Company Detail

    Table 67. Abbott Laboratories Business Overview

    Table 68. Abbott Laboratories Solid Tumor Drug Product

    Table 69. Abbott Laboratories Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 70. Abbott Laboratories Recent Development

    Table 71. Pfizer Inc Company Detail

    Table 72. Pfizer Inc Business Overview

    Table 73. Pfizer Inc Solid Tumor Drug Product

    Table 74. Pfizer Inc Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 75. Pfizer Inc Recent Development

    Table 76. Amgen Limited & Amgen Ireland Limited Company Detail

    Table 77. Amgen Limited & Amgen Ireland Limited Business Overview

    Table 78. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product

    Table 79. Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 80. Amgen Limited & Amgen Ireland Limited Recent Development

    Table 81. Bristol-Myers Squibb Company Company Detail

    Table 82. Bristol-Myers Squibb Company Business Overview

    Table 83. Bristol-Myers Squibb Company Solid Tumor Drug Product

    Table 84. Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 85. Bristol-Myers Squibb Company Recent Development

    Table 86. GlaxoSmithKline plc. Company Detail

    Table 87. GlaxoSmithKline plc. Business Overview

    Table 88. GlaxoSmithKline plc. Solid Tumor Drug Product

    Table 89. GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 90. GlaxoSmithKline plc. Recent Development

    Table 91. F. Hoffmann-La Roche Ltd. Company Detail

    Table 92. F. Hoffmann-La Roche Ltd. Business Overview

    Table 93. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product

    Table 94. F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 95. F. Hoffmann-La Roche Ltd. Recent Development

    Table 96. Eli Lilly and Company Company Detail

    Table 97. Eli Lilly and Company Business Overview

    Table 98. Eli Lilly and Company Solid Tumor Drug Product

    Table 99. Eli Lilly and Company Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 100. Eli Lilly and Company Recent Development

    Table 101. Johnson & Johnson Company Detail

    Table 102. Johnson & Johnson Business Overview

    Table 103. Johnson & Johnson Solid Tumor Drug Product

    Table 104. Johnson & Johnson Revenue in Solid Tumor Drug Business (2018-2023) & (US$ Million)

    Table 105. Johnson & Johnson Recent Development

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Solid Tumor Drug Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Solid Tumor Drug Market Share by Type: 2022 VS 2029

    Figure 3. Small Molecules Features

    Figure 4. Biologics Features

    Figure 5. Global Solid Tumor Drug Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Solid Tumor Drug Market Share by Application: 2022 VS 2029

    Figure 7. Oncology Case Studies

    Figure 8. Neurology Case Studies

    Figure 9. Radiology Case Studies

    Figure 10. Others Case Studies

    Figure 11. Solid Tumor Drug Report Years Considered

    Figure 12. Global Solid Tumor Drug Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Solid Tumor Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Solid Tumor Drug Market Share by Region: 2022 VS 2029

    Figure 15. Global Solid Tumor Drug Market Share by Players in 2022

    Figure 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Solid Tumor Drug Revenue in 2022

    Figure 18. North America Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Solid Tumor Drug Market Share by Country (2018-2029)

    Figure 20. United States Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Solid Tumor Drug Market Share by Country (2018-2029)

    Figure 24. Germany Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Solid Tumor Drug Market Share by Region (2018-2029)

    Figure 32. China Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Solid Tumor Drug Market Share by Country (2018-2029)

    Figure 40. Mexico Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Solid Tumor Drug Market Share by Country (2018-2029)

    Figure 44. Turkey Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. AstraZeneca Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 47. Biogen Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 48. Baxter Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 49. Celgene Corporation Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 50. Abbott Laboratories Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 51. Pfizer Inc Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 52. Amgen Limited & Amgen Ireland Limited Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 56. Eli Lilly and Company Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 57. Johnson & Johnson Revenue Growth Rate in Solid Tumor Drug Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed